Survival Outcomes of Uterine Malignancies in Chinese Population

• Conditions: Endometrial Neoplasms; Survival

• Registration Number: NCT03291275
• Lead Sponsor: Lei Li

Brief Summary

This study aims to determine survival outcomes (overall survival and progression-free survival) of primary uterine malignancies in China and relevant risk factors in a prospective cohort study.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-09-01
• Study First Submitted: 2017-09-20
• Study First Submitted QC: 2017-09-20
• Study First Posted: 2017-09-25
• Status Verified: 2018-02
• Last Update Submitted: 2018-02-07
• Last Update Posted: 2018-02-08
• Primary Completion: 2022-09-01
• Study Completion: 2023-09-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 10000

Inclusion Criteria

• Primary uterine malignancies.

Exclusion Criteria

• Metastatic malignancies to uterine corpus

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall survival	5 years	Survival duration from diagnosis to death
Progression-free survival	5 years	Survival duration from last treatment after remission to recurrence

Trial Locations

Locations (1)

Lei Li; 🇨🇳 Beijing, China/Beiing, China